Search Results for “” – Page 9 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Outcomes

1156 Publications found

Molecular-Guided Off-Label Targeted Therapy in a Large-Scale Precision Oncology Program.

b

JCO precision oncology

February 1, 2023

p Cancer

c Clinical outcomes Economics Highlighted Model
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.

b

European journal of cancer (Oxford, England : 1990)

February 1, 2023

p Cancer

c Change patient management Observational
[Clinically relevant molecular pathological diagnostics in breast cancer].

b

Pathologie (Heidelberg, Germany)

February 1, 2023

p Cancer

c Guide Policy Making Review
Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan.

b

The Journal of pediatrics

February 1, 2023

p Newborn Screening

c Economics Model
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.

b

EClinicalMedicine

February 1, 2023

p COVID-19

c Change patient management RCT
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial.

b

International journal of antimicrobial agents

February 1, 2023

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Cluster RCT
Implementation of High-Sensitivity Cardiac Troponin Assays in the United States.

b

Journal of the American College of Cardiology

January 24, 2023

p Cardiovascular Disease

c Change patient management Observational Operational efficiencies
Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis.

b

NPJ genomic medicine

January 20, 2023

p Cancer

c Change patient management Clinical outcomes Observational
Light Scattering Technology and MALDI-TOF MS in the microbiological fast-track of bloodstream infections: potential impact on antimicrobial treatment choices in a real-life setting.

b

Journal of medical microbiology

January 1, 2023

p MALDI-TOF MS For Microorganism Identification

c Change patient management Observational
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data.

b

Future oncology (London, England)

January 1, 2023

p Cancer

c Change patient management Clinical outcomes Observational